Skip to content. | Skip to navigation

Personal tools

Sections

Tutelles

logo Inserm      logo cnrslogo ENSL       logo ucb1

You are here: Home / Teams / Vocanson M - IEA / Publications

Publications

SELECTION OF RECENT PUBLICATIONS

 

Scientific articles

  1. Villani AP, Rozieres A, Bensaid B, Eriksson KK, Mosnier A, Albert F, Mutez V, Brassard O, Baysal T, Tardieu M, Allatif O, Fusil F, Andrieu T, Jullien D, Dubois V, Giannoli C, Gruffat H, Pallardy M, Cosset FL, Nosbaum A, Kanagawa O, Maryanski JL, Yerly D, Nicolas JF, Vocanson M. Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis. Sci Adv. 2021. 7(12):eabe0013.
  2. Hequet O, Nosbaum A, Guironnet-Paquet A, Blasco E, Nicolas-Virelizier E, Griffith T, Rigal D, Cognasse F, Nicolas JF and Vocanson M. CD8+ T cells mediate ultraviolet A-induced immunomodulation in a murine model of extracorporeal photochemotherapy. Eur J immunol. 2020. 50(5):725-735.
  3. Paul A, Braun C, Mosnier A, Lavoix A, Sagorny K, Lefebvre T, Chaigneau C, Nicolas JF, Vocanson M, Nosbaum A. Detection of skin alterations in mild-to-moderate chronic venous disease using non-invasive techniques. European Journal of Dermatology. 2020. 30(5):505-515.
  4. Gamradt P*, Laoubi L*, Nosbaum A, Mutez V, Lenief V, Grande S, Redoulès D, Schmidt AM, Nicolas JF, Vocanson M. Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy. J Allergy Clin Immunol. 2019. 143(6):2147-2157. *Equal contributors.
  5. Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P. Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients. Transfusion. 2019 Feb 12. doi: 10.1111/trf.15188.
  6. Goujon C, Viguier M, Staumont-Sallé D, Bernier C, Guillet G, Lahfa M, Ferrier Le Bouedec MC, Cambazard F, Bottigioli D, Grande S, Dahel K, Bérard F, Rabilloud M, Mercier C, Nicolas JF. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial. J Allergy Clin Immunol Pract. 2018. 6(2):562-569.
  7. Ventre E, Rozières A, Lenief V, Albert F, Rossio P, Laoubi L, Dombrowicz D, Staels B, Ulmann L, Julia V, Vial E, Jomard A, Hacini-Rachinel F, Nicolas JF, Vocanson M. Ivermectin improves allergic skin inflammation through direct inhibition of T cell activation. Allergy. 2017, 72(8):1212-1221.
  8. Bernard M, Guiraud B, Nicolas JF, Bessou-Touya S, Duplan H, Rozières A, Goujon C, Galliano MF*, Vocanson M*. IL-1beta promotes atopic dermatitis phenotype in reconstructed human epidermis. J Pathol. 2017, 242(2):234-245. *Equal contributors.
  9. Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, Maucort-Boulch D, Bérard F, D'Incan M, Kardaun SH, Nicolas JF. Comparative histological analysis of drug-induced maculopapular exanthema and DRESS. J Eur Acad Dermatol Venereol. 2016. 30(12):2085-2090.
  10. Cortial M, Rozières A, Baeck M, De Montjoye L, Grande S, Briançon S, Nicolas JF, Vocanson M. Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis. Nanomedicine. 2015, 11(4):1029-33.
  11. Vocanson M*, Achachi A*, Bastien P, Péguet-Navarro J, Grande S, Goujon C, Castiel-Higounenc I, Breton L, Nicolas JF * and Gueniche A*. UV radiation induces the epidermal recruitment of inflammatory dendritic cells that compensate for the depletion of Langerhans cells in human skin. J Invest Dermatol. 2015,135(8):2058-67.  *Equal contributors.
  12. Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, Maucort-Boulch D, Bérard F, D'Incan M, Kardaun SH, Nicolas JF. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol. 2015, 29(11):2199-205.
  13. Ben-Said B, Arnaud-Butel S, Rozières A, Rodet K, Bérard F, Nicolas JF, Nosbaum A. Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics. J Dermatol Sci. 2015, 80(1):71-4.

 

Reviews

  1. Vocanson M, Naisbitt DJ, Nicolas JF. Current perspective of the etiopathogenesis of delayed-type, and T-cell-mediated drug-related skin diseases. J Allergy Clin Immunol. 2020. 145(4):1142-1144.
  2. Khandzian M, Hacard F, Braire-Bourrel M, Jaulent C, Bérard F, Nicolas JF, Nosbaum A. NSAID urticaria: Similar management to acute urticaria. Rev Med Interne. 2019. 40(3):166-172.
  3. Goujon C, Nicolas JF, Nosbaum A. Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol.  2019. 33(4):e154-e155.
  4. Villani AP, Gamradt P, Nosbaum A, Laoubi L, Jullien D, Nicolas JF, Vocanson M. Immune-mediated skin diseases induced by chemicals and drugs. Curr Opin Toxicol. 2018, 10 :111-116.
  5. Patra V, Laoubi L, Nicolas JF, Vocanson M, Wolf P. A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells. Front Med (Lausanne). 2018. 30;5:166.
  6. Vocanson M, Mutez V, Esser PR, Cluzel M, Nosbaum A, Martin SF, Nicolas JF. Contact hypersensitivity: T-cell based assay. Curr Opin Toxicol. 2017, 5:39-45.
  7. Hoelt P, Confavreux C, Jullien D, Villani AP. Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy. G Ital Dermatol Venereol. 2017. 152(5):458-473.
  8. Bensaïd B, Valeyrie-Allanore L, Lebrun-Vignes B, Nicolas JF. Drug induced exanthema and severe cutaneous reactions.  Rev Prat. 2015. 65(7):981-5.
  9. Villani A, Demoly P, Nicolas JF. Drug hypersensitivity: definitions and mechanisms. Rev Prat. 2015. 65(7):969-71.
  10. Hacard F, Nosbaum A, Huynh VA, Nicolas JF, Bérard F. Diversity of cutaneous bacteria decreases inflammation. Ann Dermatol Venereol. 2015. 142 Suppl 1:S13-7.
  11. Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M, Aractingi S, Aubin F, Cantagrel A, Ortonne JP, Jullien D. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. J Am Acad Dermatol. 2015. 73(2):242-8.
  12. Jullien D, Prinz JC, Nestle FO. Immunogenicity of biotherapy used in psoriasis: the science behind the scenes. J Invest Dermatol. 2015. 135(1):31-38.

 

Clinical articles

  1. Castagna J, Bernard L, Hacard F, Delcroix F, Darrigade AS, Nicolas JF, Decullier E, Nosbaum A, Bérard F. Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria. Br J Dermatol. 2020.183(6):1124-1126.
  2. Pascal C, Maucort-Boulch D, Gilibert S, Bottigioli D, Verdu V, Jaulent C, Hacard F, Bérard F, Nicolas JF, Nosbaum A. Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria. J Eur Acad Dermatol Venereol. 2020. 34(10):2339-2345.
  3. Bérard F, Ferrier Le Bouedec MC, Bouillet L, Reguiai Z, Barbaud A, Cambazard F, Milpied B, Pelvet B, Kasujee I, Gharbi H, Lacour JP. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study. Br J Dermatol. 2019. 180(1):56-66.
  4. Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, Mainguy C, Nicolas JF, Nosbaum A, Jubin V. The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients. Pediatr Allergy Immunol. 2020. 31(4):396-404.
  5. Chastagner M, Hoelt P, Kanitakis J, Jullien D, Villani AP. Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin. Eur J Dermatol. 2019 Mar 2.
  6. Viel S, Pescarmona R, Belot A, Nosbaum A, Lombard C, Walzer T, Bérard F. A Case of Type 2 Hypersensitivity to Rasburicase Diagnosed with a Natural Killer Cell Activation Assay. Front Immunol. 2018. 29;9:110.
  7. Castagna J, Nosbaum A, Vial T, Rozieres A, Hacard F, Vocanson M, Pralong P, Chuniaud-Louche C, Nicolas JF, Gouraud A, Bérard F. Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity. J Allergy Clin Immunol Pract. 2018, 6(4):1409-1411.
  8. Delaunay J, Hacard F, Denery-Papini S, Garnier L, Bérard F, Nicolas JF, Nosbaum A. Occupational immediate contact allergy to hydrolysed wheat protein after cosmetic exposure. Contact Dermatitis. 2018, 78(4):291-292.
  9. Michallet M, Sobh M, Garban F, Bulabois CE, Yakoub-Agha I, Coiteux V, Dulery R, Rohrlich PS, Legrand F, Clement L, Praire A, Detrait M, Barraco F, Nicolini FE, Hequet O. Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study. Leuk Lymphoma. 2018;59(2):372-380.
  10. Yfanti I, Nosbaum A, Berard F, Nicolas JF. Methotrexate does not impede the development of contact allergy. Contact Dermatitis. 2018 Mar;78(3):223-224.
  11. Hacard F, Martin C, Verdu V, Montagnon A, Augey F, Braire-Bourrel M, Nicolas JF, Berard F, Nosbaum A. Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria. Eur J Dermatol. 2018 Dec 10. doi: 10.1684/ejd.2018.3442. [Epub ahead of print]
  12. Deschamps T, Nosbaum A, Delcroix F, Vocanson M, Berard F, Nicolas JF. Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis. Eur J Dermatol. 2018, Dec 10. doi: 10.1684/ejd.2018.3456. [Epub ahead of print].